The combination of captopril
(or other ACE inhibitors) and procainamide
possibly increases the risk of leucopenia, especially in patients with renal
impairment. No pharmacokinetic interaction occurs between captopril
It is recommended that white cell counts are monitored before concurrent use, every 2 weeks during the first 3 months of combined treatment, and then periodically thereafter.